SA

Seleena Abida

Active Director Director DIN 09538270
DIN 09538270 First appointment Mar 2022 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Seleena Abida

Data last updated:

Seleena Abida is a Director at Purnam Biotech Private Limited (since 2022). The company operates in Research & Development.

DIN 09538270
Primary Designation Director
Industry Research & Development
First Appointment 16 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Purnam Biotech Private Limited U73200KL2022PTC074509
Director16 Mar 20222022Active

Board colleagues of Seleena Abida

NameDINCompanyDesignation
Muhammed Bin Farooq09538269Purnam Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Purnam Biotech Private Limited
Premium access

Shareholding and investment profile for Seleena Abida

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seleena Abida

Seleena Abida currently holds 1 directorship: Purnam Biotech Private Limited (Director, since 16 Mar 2022).

Seleena Abida was first appointed on 16 Mar 2022 as Director at Purnam Biotech Private Limited.

The current boards of Seleena Abida's companies include Muhammed Bin Farooq (Purnam Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available